Apex Immune is a company headquartered in the United States.
Apex Immune develops innovative monoclonal and bispecific/multi-specific antibody-based immunotherapies targeting cancer and autoimmune diseases, focusing on enhancing immune cell function to treat patients resistant to available therapies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.